Published in Chest on May 01, 2000
Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer (2006) 2.73
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care (2006) 1.74
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res (2012) 1.35
Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med (2013) 1.31
Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 1.28
Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer (2009) 1.26
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.21
Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol (2013) 1.16
Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population. J Thorac Oncol (2010) 1.10
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg (2008) 1.10
Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer (2005) 1.07
Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol (2008) 1.05
Using claims-based measures to predict performance status score in patients with lung cancer. Cancer (2010) 1.05
Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res (2006) 1.04
Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer. J Oncol Pract (2013) 1.01
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer (2012) 0.97
Treatment for hepatocellular carcinoma in elderly patients: a literature review. J Cancer (2013) 0.97
Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer. Clin Lung Cancer (2013) 0.96
Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium. Cancer (2014) 0.93
Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Lung Cancer (2011) 0.92
Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey. Cancer (2010) 0.92
Use of chemotherapy at the end of life in a Portuguese oncology center. Support Care Cancer (2007) 0.91
Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States. J Geriatr Oncol (2015) 0.91
Health economics of a palliative care unit for terminal cancer patients: a retrospective cohort study. Support Care Cancer (2010) 0.88
Does gender influence emergency department management and outcomes in geriatric abdominal pain? J Emerg Med (2008) 0.85
Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy. J Cancer Res Clin Oncol (2010) 0.84
Lung cancer 7: management of lung cancer in elderly patients. Thorax (2003) 0.84
Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database. J Thorac Oncol (2013) 0.84
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib. Br J Cancer (2004) 0.82
The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada. Curr Oncol (2008) 0.82
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials. Am J Clin Oncol (2016) 0.82
Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer. Br J Cancer (2006) 0.81
Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol. BMJ Open (2016) 0.81
Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer. Cancer (2008) 0.80
Disparities in Lung Cancer Care and Outcomes among Elderly in a Medically Underserved State Population-A Cancer Registry-Linked Database Study. Popul Health Manag (2015) 0.79
Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba. Curr Oncol (2011) 0.79
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer (2014) 0.76
Perspectives of African Americans on lung cancer: a qualitative analysis. Oncologist (2015) 0.76
Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. Lung Cancer (2016) 0.75
Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study. BMC Health Serv Res (2016) 0.75
Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer. Lung Cancer (2016) 0.75
Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancer. Psychooncology (2014) 0.75
Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer. Am J Clin Oncol (2015) 0.75
Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies. Target Oncol (2017) 0.75
Decisions for lung cancer chemotherapy: the influence of physician and patient factors. Support Care Cancer (2011) 0.75
Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol (2013) 9.68
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol (2009) 9.18
Performance of a five-item mental health screening test. Med Care (1991) 8.76
Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med (1977) 8.60
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 8.52
Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal (1995) 7.45
Use of alternative medicine by women with early-stage breast cancer. N Engl J Med (1999) 7.37
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol (2007) 7.33
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80
Symptoms and suffering at the end of life in children with cancer. N Engl J Med (2000) 6.75
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA (2000) 6.37
Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet (2001) 6.07
Analysis of survival by tumor response. J Clin Oncol (1983) 5.91
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Prostate cancer screening: what we know and what we need to know. Ann Intern Med (1993) 5.84
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol (2005) 5.41
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA (1997) 5.36
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol (2001) 5.31
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 5.22
The cost of a successful delivery with in vitro fertilization. N Engl J Med (1994) 4.94
Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry (1987) 4.62
Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making (1985) 4.47
Gains in life expectancy from medical interventions--standardizing data on outcomes. N Engl J Med (1998) 4.47
Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med (1995) 4.03
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood (2001) 3.93
Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med (1997) 3.84
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet (2000) 3.79
Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation (1991) 3.75
Modeling for health care and other policy decisions: uses, roles, and validity. Value Health (2001) 3.56
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst (1998) 3.50
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA (1999) 3.37
Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health (1985) 3.31
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol (1996) 3.30
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 3.17
Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care (1999) 3.15
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst (2001) 3.00
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst (1996) 2.91
Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst (2001) 2.85
Use and misuse of the term "cost effective" in medicine. N Engl J Med (1986) 2.82
Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA (2000) 2.81
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol (2006) 2.72
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med (2000) 2.71
The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69
Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA (2000) 2.58
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. J Clin Oncol (1989) 2.57
Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care (1995) 2.55
Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension. N Engl J Med (1977) 2.54
When doctors meet numbers. Am J Med (1981) 2.48
A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health (1988) 2.46
Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care (2000) 2.41
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol (2001) 2.37
What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics. J Med Ethics (2003) 2.36
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA (1999) 2.35
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Ann Oncol (2008) 2.26
Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med (1991) 2.25
Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med (2000) 2.21
Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18
Preference-based measures in economic evaluation in health care. Annu Rev Public Health (2000) 2.18
A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data. Stat Med (2000) 2.17
On the decision rules of cost-effectiveness analysis. J Health Econ (1993) 2.09
The cost-effectiveness of air bags by seating position. JAMA (1997) 2.09
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol (2001) 2.05
Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med (1997) 2.03
Systematic overview of cost-utility assessments in oncology. J Clin Oncol (2000) 2.02
Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA (1990) 2.01
Outcome of pregnancy in survivors of Wilms' tumor. JAMA (1987) 2.00
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol (1992) 2.00
Cost and health implications of cholesterol lowering. Circulation (1992) 2.00
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med (1994) 1.97
Preferences for health outcomes. Comparison of assessment methods. Med Decis Making (1984) 1.97
Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer (2000) 1.97
What do patients value? Willingness to pay for ultrasound in normal pregnancy. Med Care (1985) 1.96
The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis (2001) 1.93
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol (2000) 1.92
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92
Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol (2000) 1.91
Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care (1998) 1.88
Elective hysterectomy. Benefits, risks, and costs. Med Care (1985) 1.87
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology (1999) 1.87
Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol (2001) 1.86
Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care (1999) 1.85
Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health (1994) 1.84
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer (1997) 1.82
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol (2000) 1.81
Cost of care for cancer in a health maintenance organization. Health Care Financ Rev (1997) 1.81
Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol (2001) 1.79
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet (2001) 1.79